Literature DB >> 24813226

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Daniela Gilardi1, Gionata Fiorino, Marco Genua, Mariangela Allocca, Silvio Danese.   

Abstract

The use of complementary and alternative medicine is wide-spread not only in Eastern countries, but also in the Western world. Despite the increasing evidence on the harmful effects induced by several naturopathic/homeopathic products, patients seem to appreciate these remedies, in particular because they consider them to be absolutely safe. This same phenomenon is common among inflammatory bowel disease (IBD) patients. As a result there is a significant request for scientific data to evaluate both the efficacy and safety of these remedies, and to support the use of such medications as adjuvant treatments to biological and synthetic drugs. We aimed to review the current evidence on efficacy and safety of some natural products that are believed to be effective in inflammatory bowel disease. Further perspectives for the clinical use of herbal products and strategies for improving knowledge about herbal products in IBD are also discussed.

Entities:  

Keywords:  Crohn’s disease; boswellic acid; complementary and alternative medicine; curcumin; herbal medicine; inflammatory bowel disease; pomegranate; ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24813226     DOI: 10.1586/17474124.2014.917954

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  6 in total

Review 1.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

2.  Coumaric acid ameliorates experimental colitis in rats through attenuation of oxidative stress, inflammatory response and apoptosis.

Authors:  Maryam Ghasemi-Dehnoo; Hossein Amini-Khoei; Zahra Lorigooini; Korosh Ashrafi-Dehkordi; Mahmoud Rafieian-Kopaei
Journal:  Inflammopharmacology       Date:  2022-10-03       Impact factor: 5.093

Review 3.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

4.  Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.

Authors:  Maximilian Kutschera; Thomas Waldhör; Gottfried Novacek; Wolfgang Miehsler; Hans Peter Gröchenig; Thomas Haas; Heimo Wenzl; Pius Steiner; Robert Koch; Thomas Feichtenschlager; Gerald Eckhardt; Andreas Mayer; Andreas Kirchgatterer; Othmar Ludwiczek; Reingard Platzer; Pavol Papay; Johanna Gartner; Harry Fuchssteiner; Paul-Gerhard Peters; Gerhard Reicht; Gabriele Moser; Clemens Dejaco; Harald Vogelsang; Christian Primas
Journal:  United European Gastroenterol J       Date:  2021-02-18       Impact factor: 4.623

5.  Gallincin ameliorates colitis-associated inflammation and barrier function in mice based on network pharmacology prediction.

Authors:  De-Jun Cui; Xiao-Lan Yang; Shujiro Okuda; Yi-Wei Ling; Zhu-Xue Zhang; Qi Liu; Wen-Qiang Yuan; Fang Yan
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

Review 6.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.